Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Pharmacogenomics|April 14, 2006
CACNA1C polymorphisms are associated with the efficacy of calcium channel blockers in the treatment of hypertensionTroy Bremer, Albert Man, Kalev Kask, et al.
Molecular Diagnosis & Therapy|June 16, 2007
The pharmacogenetics of lithium response depends upon clinical co-morbidityTroy Bremer, Cornelius Diamond, Rebecca McKinney, et al.
Frontiers in Oncology|June 5, 2023
Analytical validation of the 7-gene biosignature for prediction of recurrence risk and radiation therapy benefit for breast ductal carcinomaDavid Dabbs, Karuna Mittal, Scott Heineman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2021
High PDGFRb Expression Predicts Resistance to Radiotherapy in DCIS within the SweDCIS Randomized TrialCarina Strell, Dick Folkvaljon, Erik Holmberg, et al.
European Journal of Cancer (Oxford, England : 1990)|March 3, 2022
Tumour-infiltrating lymphocytes add prognostic information for patients with low-risk DCIS: findings from the SweDCIS randomised radiotherapy trialAglaia Schiza, Viktoria Thurfjell, Axel Stenmark Tullberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2018
A Biological Signature for Breast Ductal Carcinoma In Situ to Predict Radiotherapy Benefit and Assess Recurrence RiskTroy Bremer, Pat W Whitworth, Rakesh Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2020
Validation of a Ductal Carcinoma In Situ Biomarker Profile for Risk of Recurrence after Breast-Conserving Surgery with and without RadiotherapySheila Weinmann, Michael C Leo, Melanie Francisco, et al.
Clinical Breast Cancer|October 1, 2024
A 7-Gene Biosignature for Ductal Carcinoma in situ of the Breast Identifies Subpopulations of HER2-positive Patients With Distinct Recurrence Rates After Breast-Conserving Surgery and Radiation TherapyFrank Vicini, Chirag Shah, Karuna Mittal, et al.
Cancers|December 10, 2021
Prognostic Risk Assessment and Prediction of Radiotherapy Benefit for Women with Ductal Carcinoma In Situ (DCIS) of the Breast, in a Randomized Clinical Trial (SweDCIS)Fredrik Wärnberg, Per Karlsson, Erik Holmberg, et al.
International Journal of Radiation Oncology, Biology, Physics|September 17, 2022
A Novel Biosignature Identifies Patients With DCIS With High Risk of Local Recurrence After Breast Conserving Surgery and Radiation TherapyFrank A Vicini, G Bruce Mann, Chirag Shah, et al.
Pageof 2